A randomized, double-blind, cross-over study of the cognitive and mood effects of Keppra (levetiracetam) tablets in healthy older adults
Latest Information Update: 21 May 2022
Price :
$35 *
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- 17 May 2022 Status changed from recruiting to completed.
- 04 Dec 2007 Results have been presented at AES 2007.
- 25 Aug 2006 New trial record.